Patent · US Active

Inhibitors of c-Met and uses thereof

US7728017B2 · kind B2 · utility

8Cited by

0References

6Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

David J. Lauffer · Saline, US
Alexander Aronov · Watertown, US
Pan Li · Lexington, US
David Deininger · New Brunswick, US
Kira McGinty · Schenectady, US
Dean Stamos · Carlsbad, US
Jon Come · Cambridge, US
Michelle L. Stewart · Cambridge, US

Key dates

Filing date	Nov 30, 2006
Grant date	Jun 1, 2010
Priority date	—
Expiry date	Jul 23, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.